2025-10-20 - Analysis Report
Okay, here's an analysis of Natera (NTRA) based on the provided data, presented in an English report format with a focus on key numerical indicators and straightforward analysis.

## Natera Inc. (NTRA) Stock Analysis

**Company Overview:** Natera Inc. is a diagnostics company specializing in cell-free DNA testing.

**1. Performance vs. S&P 500 (VOO)**

*   **NTRA Cumulative Return:** 87.80%
*   **VOO Cumulative Return:** 97.31%
*   **Return Disparity:** -9.5%
*   **Relative Disparity:** 30.0 (Indicates Natera is positioned at the 30th percentile of its historical return disparity range compared to VOO).

**Analysis:** Natera has underperformed the S&P 500 (VOO) over the analyzed period, with a cumulative return difference of -9.5%.  The relative disparity suggests that the current underperformance is closer to the lower end of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2015-2017  | -10.0%  | 70.1% | -34.0%  | -0.2   | 1.2    |
| 2016-2018  | 22.0%   | 80.0% | 6.0%    | 0.1    | 1.9    |
| 2017-2019  | 50.0%   | 80.0% | 28.0%   | 1.0    | 4.6    |
| 2018-2020  | 186.0%  | 80.5% | 163.0%  | 1.1    | 13.7   |
| 2019-2021  | 96.0%   | 80.5% | 49.0%   | 1.6    | 12.8   |
| 2020-2022  | -77.0%  | 80.5% | -76.0%  | 0.1    | 5.5    |
| 2021-2023  | -194.0% | 76.6% | -195.0% | -1.1   | 8.6    |
| 2022-2024  | 8.0%    | 76.6% | -13.0%  | -1.2   | 21.7   |
| 2023-2025  | 115.0%  | 76.6% | 53.0%   | 0.1    | 24.9   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  NTRA's CAGR has fluctuated significantly over different periods, showing high growth in some periods (e.g., 2018-2020) and substantial declines in others (e.g., 2021-2023).
*   **MDD (Maximum Drawdown):**  MDD remains high across all periods, indicating significant volatility and risk.
*   **Alpha:** Alpha values show periods of outperformance (positive alpha) and underperformance (negative alpha) relative to the benchmark. Recent years show strong negative alpha.
*   **Beta:** Beta values are variable, indicating that NTRA's sensitivity to market movements changes over time.

**2. Recent Stock Price Movement**

*   **Current Price:** 181.69
*   **Previous Close:** 180.54
*   **Change:** 0.64
*   **5-Day Moving Average:** 177.73
*   **20-Day Moving Average:** 169.36
*   **60-Day Moving Average:** 162.68

**Analysis:** The stock price has increased slightly compared to the previous close. The current price is above all three moving averages (5-day, 20-day, and 60-day), suggesting an upward trend in the short to medium term.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment Recommended)
*   **RSI (Relative Strength Index):** 79.39 (Overbought)
*   **PPO (Percentage Price Oscillator):** 0.80
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (6 shares - Very Safe - MRI:0.90)
*   **20-Day Relative Disparity Change:** 3.6 (+) (Short-term Increase)
*   **Expected Return:** -108.8%

**Analysis:**

*   The MRI suggests a "Low Investment Recommended" indicating moderate risk.
*   The RSI is in overbought territory, which could signal a potential pullback.
*   The positive change in relative disparity over the past 20 days indicates short-term upward momentum.
*   The negative expected return suggests potential underperformance compared to the S&P 500 over the long term.

**4. Recent News & Significant Events**

*   **Positive Headlines:**  Recent news indicates positive developments, including recognition in "Fast Company's Next Big Things in Tech" and promising study results for the Signatera platform.
*   **Investor Call:** Upcoming investor call to discuss ESMO findings could provide further insights.
*   **Valuation Discussions:**  Articles discussing the valuation of Natera and its long-term potential.

**Analysis:** The recent news flow appears generally positive, particularly regarding the Signatera platform and its potential applications. The investor call could be a catalyst for further stock movement.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.53)
*   **Opinions:** 19
*   **Target Price:** Average: $193.95, High: $235.00, Low: $37.00

**Analysis:** The analyst consensus is "Buy," with a significant upside potential based on the average target price.  However, the wide range between the high and low target prices indicates differing opinions and uncertainty.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue   |
|------------|-------|-----------|
| 2025-08-08 | -0.74 | 0.55 B$   |
| 2025-05-09 | -0.5  | 0.50 B$   |
| 2024-11-12 | -0.26 | 0.44 B$   |
| 2024-08-09 | -0.3  | 0.41 B$   |
| 2025-08-08 | -0.3  | 0.41 B$   |

**Analysis:** While revenue has generally increased over the past quarters, Natera continues to report negative EPS (Earnings Per Share), indicating ongoing losses.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $0.55B   | 63.41%        |
| 2025-03-31 | $0.50B   | 63.12%        |
| 2024-12-31 | $0.48B   | 62.94%        |
| 2024-09-30 | $0.44B   | 61.79%        |
| 2024-06-30 | $0.41B   | 58.83%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-06-30 | $1.25B   | -8.10%  |
| 2025-03-31 | $1.24B   | -5.40%  |
| 2024-12-31 | $1.20B   | -4.50%  |
| 2024-09-30 | $0.88B   | -3.60%  |
| 2024-06-30 | $0.84B   | -4.48%  |

**Analysis:**

*   Revenue has consistently increased, and the profit margin is relatively high and improving.
*   Equity has also increased.
*   ROE (Return on Equity) is negative, reflecting the company's continued losses despite revenue growth.

**7. Overall Analysis**

Natera exhibits a mixed profile.  It's a growth-oriented company with increasing revenue and high profit margins.  Recent news and analyst sentiment are generally positive. However, the company is not yet profitable, and its stock price has underperformed the S&P 500 over the analyzed period.  The high RSI suggests a potential short-term pullback, while the negative expected return indicates long-term concerns.

**Investment Recommendation:** Given the conflicting signals, a cautious approach is warranted.  Investors should carefully consider their risk tolerance and conduct further due diligence before investing in NTRA.  Monitoring the upcoming investor call and future earnings reports is crucial.
